Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma, Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05633615
What this trial is testing

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaGrade 3b Follicular LymphomaPrimary Mediastinal (Thymic) Large B-Cell Lymphoma+4 more
SWOG Cancer Research Network 396
Testing effectiveness (Phase 2)Study completedNCT02348216
What this trial is testing

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B-Cell LymphomaTransformed Follicular Lymphoma (TFL)+2 more
Kite, A Gilead Company 307
Testing effectiveness (Phase 2)Study completedNCT03147404
What this trial is testing

Phase II Study of Avelumab in Metastatic Gastronetro-pancreatic （GEP） Neuroendocrine Carcinoma （NEC, WHO Grade 3） as Second-line Treatment After Failing to Etoposide+Cisplatin: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes

Who this might be right for
Neuroendocrine Carcinoma, Grade 3
Samsung Medical Center 14
Not applicableEnded earlyNCT01609036
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma

Who this might be right for
Lymphoma, Follicular
Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Study completedNCT01693614
What this trial is testing

Safety and Efficacy of BKM120 in Relapsed and Refractory NHL

Who this might be right for
Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Novartis Pharmaceuticals 72
Not applicableLooking for participantsNCT05816850
What this trial is testing

Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 654
Testing effectiveness (Phase 2)Active Not RecruitingNCT04257578
What this trial is testing

Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma+5 more
University of Washington 23
Testing effectiveness (Phase 2)Ended earlyNCT02877082
What this trial is testing

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

Who this might be right for
Acute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more
Emory University 5
Testing effectiveness (Phase 2)Looking for participantsNCT06510361
What this trial is testing

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Who this might be right for
LymphomaFollicular LymphomaLymphoma,Non-Hodgkin+1 more
Beth Israel Deaconess Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT03583424
What this trial is testing

Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Hematopoietic Cell Transplantation RecipientRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+9 more
Ohio State University Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00989586
What this trial is testing

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Beth Christian 35
Testing effectiveness (Phase 2)Ended earlyNCT01307605
What this trial is testing

Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 154
Early research (Phase 1)Looking for participantsNCT07422610
What this trial is testing

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Advanced Malignancies and Hepatic Impairment
Novartis Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT00026182
What this trial is testing

Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI) 99
Post-approval studies (Phase 4)Study completedNCT01126242
What this trial is testing

Tape Versus Semirigid Versus Lace-up Ankle Support in the Treatment of Acute Lateral Ankle Ligament Injury.

Who this might be right for
Grade II and III Acute Lateral Ankle Ligament Injuries
Gelre Hospitals 182
Testing effectiveness (Phase 2)Ended earlyNCT01119794
What this trial is testing

Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab

Who this might be right for
Lymphoma, Non-Hodgkins
Brown University 10
Not applicableStudy completedNCT06509477
What this trial is testing

Effectiveness and Safety Comparison of Lunaphil Ultra (Hyaluronic Acid, by Espad Pharmed Co.) Versus Juvederm Ultra 4® (Hyaluronic Acid, by Allergan Co.) in Nasolabial Folds (NLFs) Management

Who this might be right for
Moderate or Severe Nasolabial Folds
Espad Pharmed 104
Not applicableUnknownNCT05855395
What this trial is testing

The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

Who this might be right for
COVID-19
Huashan Hospital 5,815
Large-scale testing (Phase 3)Study completedNCT00002565
What this trial is testing

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 61
Not applicableNot Yet RecruitingNCT07334873
What this trial is testing

Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress Syndrome

Who this might be right for
ARDS (Moderate or Severe)
Nanfang Hospital, Southern Medical University 536
Next Page